Growth Metrics

Idexx Laboratories (IDXX) Deferred Taxes (2016 - 2026)

Idexx Laboratories has reported Deferred Taxes over the past 17 years, most recently at $31.5 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 574.27% year-over-year to $31.5 million; the TTM value through Dec 2025 reached $131.2 million, up 642.3%, while the annual FY2025 figure was $131.2 million, 642.3% up from the prior year.
  • Deferred Taxes for Q4 2025 was $31.5 million at Idexx Laboratories, down from $93.2 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $93.2 million in Q3 2025 and troughed at -$33.6 million in Q4 2023.
  • A 5-year average of $1.0 million and a median of -$2.2 million in 2023 define the central range for Deferred Taxes.
  • Biggest five-year swings in Deferred Taxes: plummeted 9186.81% in 2022 and later surged 1461.48% in 2025.
  • Year by year, Deferred Taxes stood at -$7.4 million in 2021, then skyrocketed by 124.58% to $1.8 million in 2022, then plummeted by 1938.74% to -$33.6 million in 2023, then skyrocketed by 113.93% to $4.7 million in 2024, then skyrocketed by 574.27% to $31.5 million in 2025.
  • Business Quant data shows Deferred Taxes for IDXX at $31.5 million in Q4 2025, $93.2 million in Q3 2025, and $2.5 million in Q2 2025.